Targeting the Peripheral Inflammatory Response to Stroke: Role of the Spleen

Translational Stroke Research

Volumn 5, Issue 6, 2014, Pages 635-637

  Pennypacker, Keith R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

BRAIN HEMORRHAGE; CELL MIGRATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CYTOKINE RELEASE; EDITORIAL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SPLEEN FUNCTION; SPLEEN SIZE; SPLENECTOMY; TH1 CELL; TH2 CELL; TRAUMATIC BRAIN INJURY; ANIMAL; ENCEPHALITIS; IMMUNOLOGY; METABOLISM; SPLEEN; STROKE; SURGERY;

ANIMALS; ENCEPHALITIS; HUMANS; INFLAMMATION; SPLEEN; STROKE;

EID: 84922073577     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0372-8     Document Type: Editorial

References (42)

1. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol. 1994;55(2):195–203.
2. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab. 1995;15(1):42–51.
3. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res. 2002;932(1–2):110–9.
4. Tang XN, Zheng Z, Yenari MA. Bone marrow chimeras in the study of experimental stroke. Transl Stroke Res. 2012;3(3):341–7. doi:10.1007/s12975-012-0169-6.
5. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725–36.
6. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab acute stroke trial. Neurology. 2001;57(8):1428–34.
7. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR, et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol. 2006;199(1):191–200.
8. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176(11):6523–31.
9. Ajmo CT, Jr., Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009.
10. Sahota P, Vahidy F, Nguyen C, Bui TT, Yang B, Parsha K, et al. Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke. 2013;8(2):60–7.
11. Ajmo Jr CT, Vernon DO, Collier L, Hall AA, Garbuzova-Davis S, Willing A, et al. The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res. 2008;86:2227–34. doi:10.1002/jnr.21661.
12. Jin R, Zhu X, Liu L, Nanda A, Granger DN, Li G. Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke. 2013;44(4):1135–43. doi:10.1161/STROKEAHA.111.000633.
13. Ostrowski R, Schulte R, Nie Y, Ling T, Lee T, Manaenko A, et al. Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model. Transl Stroke Res. 2012;3:473–81. doi:10.1007/s12975-012-0206-5.
14. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain. 2008;131(Pt 3):616–29.
15. Li M, Li F, Luo C, Shan Y, Zhang L, Qian Z, et al. Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury. J Trauma. 2011;71(1):141–7.
16. Das M, Leonardo CC, Rangooni S, Mohapatra SS, Mohapatra S, Pennypacker KR. Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats. J Neuroinflammation. 2011;8:148.
17. Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol. 2010;225(2):341–52.
18. Okuaki Y, Miyazaki H, Zeniya M, Ishikawa T, Ohkawa Y, Tsuno S, et al. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver. 1996;16(3):188–94.
19. Savas MC, Ozguner M, Ozguner IF, Delibas N. Splenectomy attenuates intestinal ischemia-reperfusion-induced acute lung injury. J Pediatr Surg. 2003;38(10):1465–70.
20. Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery. 2007;141(1):32–40.
21. Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, et al. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res. 2010;107(11):1364–73.
22. Schwarting S, Litwak S, Hao W, Bahr M, Weise J, Neumann H. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke. 2008;39(10):2867–75.
23. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007;27(11):1798–805.
24. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26(5):654–65.
25. Seifert HA, Leonardo CC, Hall AA, Rowe DD, Collier LA, Benkovic SA, et al. The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling. Metab Brain Dis. 2012;27(2):131–41. doi:10.1007/s11011-012-9283-0.
26. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation. 2006;113(17):2105–12.
27. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192–9. doi:10.1038/nm.1927.
28. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134(Pt 3):704–20. doi:10.1093/brain/awr008.
29. Seifert HA, Collier LA, Chapman CB, Benkovic SA, Willing AE, Pennypacker KR. Pro-inflammatory interfon gamma signaling is directly associated with stroke induced neurodegeneration. J Neuroimmune Pharmacology. 2014. doi:10.1007/s11481-014-9560-2.
30. Becker KJ, Kalil AJ, Tanzi P, Zierath DK, Savos AV, Gee JM et al. Autoimmune responses to the brain after stroke are associated with worse outcome. Stroke. 2011.
31. Becker K. Autoimmune responses to brain following stroke. Transl Stroke Res. 2012;3(3):310–7. doi:10.1007/s12975-012-0154-0.
32. Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR. A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol. 2012;7(4):1017–24. doi:10.1007/s11481-012-9406-8.
33. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem. 2001;276(5):2986–91.
34. Offner H, Dotson AL, Zhu W, Libal N, Alkayed NJ. Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy. Front Cell Neurosci. 2014:(in press). doi: 10.3389/fncel.2014.00284.
35. Leonardo CC, Musso J, Das M, Rowe DD, Collier LA, Mohapatra S, et al. CCL20 is associated with neurodegeneration following experimental traumatic brain injury and promotes cellular toxicity in vitro. Transl Stroke Res. 2012;3(3):357–63.
36. Zhang M, Mahadevan A, Amere M, Li H, Ganea D, Tuma RF. Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke. Transl Stroke Res. 2012;3(3):348–56. doi:10.1007/s12975-012-0197-2.
37. Switzer JA, Sikora A, Ergul A, Waller JL, Hess DC, Fagan SC. Minocycline prevents IL-6 increase after acute ischemic stroke. Transl Stroke Res. 2012;3(3):363–8. doi:10.1007/s12975-012-0150-4.
38. Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Translational stroke research. 2012;3(3). doi: 10.1007/s12975-012-0187-4.
39. Rodrigues MC, Voltarelli JC, Sanberg PR, Borlongan CV, Garbuzova-Davis S. Immunological aspects in amyotrophic lateral sclerosis. Transl Stroke Res. 2012;3(3):331–40. doi:10.1007/s12975-012-0177-6.
40. Golden JE, Shahaduzzaman M, Wabnitz A, Green S, Womble TA, Sanberg PR, et al. Human umbilical cord blood cells alter blood and spleen cell populations after stroke. Transl Stroke Res. 2012;3(4):491–9. doi:10.1007/s12975-012-0208-3.
41. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res. 2003;73(6):778–86. doi:10.1002/jnr.10691.
42. Hetz RA, Bedi SS, Olson S, Olsen A, Cox Jr CS. Progenitor cells: therapeutic targets after traumatic brain injury. Transl Stroke Res. 2012;3(3):318–23. doi:10.1007/s12975-012-0192-7.